bd Capital Partners’ Investment in Ascenti

McDermott Will & Emery advised bd Capital Partners Limited in the acquisition financing of Ascenti.

bd-capital, the pan-European, operationally-led private equity firm, executed its second investment into Ascenti, a technology-led disruptor in the UK physiotherapy and mental wellbeing markets, which includes an asset backed lending component provided by M&G.

Ascenti is the leading independent provider of physiotherapy, mental health and selected clinical outsourcing services in the UK. They are a trusted partner to more than 20 NHS Clinical Commissioning Groups (CCGs) and hundreds of private businesses across the UK, serving NHS patients, pay as you go customers and private medical insurance members.

bd-Capital is a European firm dedicated to implement the next evolution of operationally-led investing: business leaders and private equity investors working in full partnership with company stakeholders. The firm targets control or co-control investments in European mid-market businesses with strong growth potential. The firm’s strategy is to invest in businesses where changing patterns in behaviour and technology disruption are creating growth opportunities.

McDermott’s team was led by finance partner Aymen Mahmoud (Picture) and included partner Mark Fine, associate Giulia Venanzoni and trainee Ryan Clarke.

Involved fees earner: Mark Fine – McDermott Will & Emery; Aymen Mahmoud – McDermott Will & Emery; Giulia Venanzoni – McDermott Will & Emery;

Law Firms: McDermott Will & Emery;

Clients: bd-capital;

Author: Federica Tiefenthaler